Clinical Trial Update: A Study of Inhaled AZD8630 in Adolescents With Asthma [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating inhaled AZD8630 in adolescents with asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AZD8630

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 1 | Status: COMPLETED